Review



clu elisa kit  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems clu elisa kit
    Clu Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 39 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clu elisa kit/product/R&D Systems
    Average 93 stars, based on 39 article reviews
    clu elisa kit - by Bioz Stars, 2026-03
    93/100 stars

    Images



    Similar Products

    93
    R&D Systems clu elisa kit
    Clu Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clu elisa kit/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    clu elisa kit - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    93
    R&D Systems human clu
    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the <t>CLU</t> locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected <t>by</t> <t>ELISA</t> from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.
    Human Clu, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human clu/product/R&D Systems
    Average 93 stars, based on 1 article reviews
    human clu - by Bioz Stars, 2026-03
    93/100 stars
      Buy from Supplier

    91
    Cusabio dog clusterin
    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the <t>CLU</t> locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected <t>by</t> <t>ELISA</t> from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.
    Dog Clusterin, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/dog clusterin/product/Cusabio
    Average 91 stars, based on 1 article reviews
    dog clusterin - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    91
    Cusabio competitive canine specific elisa assay
    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the <t>CLU</t> locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected <t>by</t> <t>ELISA</t> from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.
    Competitive Canine Specific Elisa Assay, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/competitive canine specific elisa assay/product/Cusabio
    Average 91 stars, based on 1 article reviews
    competitive canine specific elisa assay - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    91
    Cusabio canine specific elisa kit targeting clusterin
    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the <t>CLU</t> locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected <t>by</t> <t>ELISA</t> from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.
    Canine Specific Elisa Kit Targeting Clusterin, supplied by Cusabio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/canine specific elisa kit targeting clusterin/product/Cusabio
    Average 91 stars, based on 1 article reviews
    canine specific elisa kit targeting clusterin - by Bioz Stars, 2026-03
    91/100 stars
      Buy from Supplier

    90
    Abnova clu (mouse) elisa kit abnova cat# ka2466
    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the <t>CLU</t> locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected <t>by</t> <t>ELISA</t> from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.
    Clu (Mouse) Elisa Kit Abnova Cat# Ka2466, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clu (mouse) elisa kit abnova cat# ka2466/product/Abnova
    Average 90 stars, based on 1 article reviews
    clu (mouse) elisa kit abnova cat# ka2466 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Abnova clu (mouse) elisa kit
    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the <t>CLU</t> locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected <t>by</t> <t>ELISA</t> from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.
    Clu (Mouse) Elisa Kit, supplied by Abnova, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/clu (mouse) elisa kit/product/Abnova
    Average 90 stars, based on 1 article reviews
    clu (mouse) elisa kit - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Jingmei Biotech Co Ltd human clu elisa kit
    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the <t>CLU</t> locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected <t>by</t> <t>ELISA</t> from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.
    Human Clu Elisa Kit, supplied by Jingmei Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human clu elisa kit/product/Jingmei Biotech Co Ltd
    Average 90 stars, based on 1 article reviews
    human clu elisa kit - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the CLU locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected by ELISA from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.

    Journal: medRxiv

    Article Title: Alzheimer’s disease protective allele of Clusterin modulates neuronal excitability through lipid-droplet-mediated neuron-glia communication

    doi: 10.1101/2024.08.14.24312009

    Figure Lengend Snippet: (A) Schematic research design. ATAC-seq was performed to identify OCRs and GWAS risk SNPs that showed ASoC in iPSC Glutaminergic (iGlut), GABAergic (iGABA), and dopaminergic (iDA) neurons, microglia (iMG) and astrocytes (iAst), which is followed by transcription factor (TF) binding prediction to confirm putative functional AD risk SNP, CRIPSR-cas9 SNP editing, and functional assays in cells. (B) ASoC mapping identifies intronic rs1532278 as a putatively functional SNP among several other GWAS risk SNPs equally associated with AD at the CLU locus. Note that rs1532278 is the only SNP within the neuronal OCR with a stronger OCR peak in iGlut. (C) T and C alleles of rs1532278 show differential allelic ATAC-seq reads (i.e., ASoC) in iGlut. The bottom panel shows the two most conserved TF binding motifs at the SNP site. (D) Schematic CLU gene structure near rs1532278 (upper panel) and a diagram showing CRISPR-Cas9 editing of rs1532278 in two iPSC lines (CD05 and CD07; T/C) to covert T/C lines to isogenic T/T and C/C lines (middle panel). Representative images of iGlut of all three genotypes are also shown (bottom panel); MAP2 and HuNu (human nuclear antigen) staining shows the morphology of iGlut and neuron purity in iGlut-mAst co-cultures. (E-F) ISL2 ChIP-qPCR on day 30 iGlut-mAst co-cultures. n=3 replicates from one clone per line. (G-H) ISL2 siRNA knockdown in day-30 pure iGlut cultures. Samples of 72 hours post-siRNA transfection were used for qPCR. n=3 replicates from one clone per line. (I) Neuronal CLU mRNA level in isogenic iGlut-mAst co-cultures of different genotype of rs1532278 (human-specific CLU qPCR assay was used). n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (J) Secreted CLU (sCLU) detected by ELISA from the supernatant of iGlut-mAst co-cultures. n=4 per group (2 clones per line, 2 replicates per clone). (K-L) Immunofluorescence staining of CLU in day 23-25 pure iGlut cultures. n=12 coverslips per group of two independent experiments (In total: 2 clones per line and 6 coverslips for each clone; and 5-6 cells per coverslip). (M) CLU mRNA level in the gray matter of postmortem brains of patients with AD and controls. Violin plots show data median and interquartile range, all other graphs show data mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001. Scale bars are indicated in each image.

    Article Snippet: ELISA quantifications of human CLU (DCLU00, R&D system, specific for human CLU), human Aβ 1-40 (DAB140B, R&D system), and human Aβ 1-42 (DAB142, R&D system) were performed according to the vendors’ protocol.

    Techniques: Binding Assay, Functional Assay, CRISPR, Staining, Knockdown, Transfection, Clone Assay, Enzyme-linked Immunosorbent Assay, Immunofluorescence

    (A) Multiz alignment and phyloP conservation (470 mammals) around rs1532278 (from UCSC hg38 genome browser). (B) JASPAR predicted TF binding sites at rs1532278 and TF expression levels in iGlut (10/23 predicted TFs can be detected by RNA seq). CPM, counts per million reads. (C) DRGX ChIP-qPCR for iGlut-mAst co-cultures of CD07 line on day 30. n=3 per group (one clone with 3 replicates from the CD07 line). (D) CLU mRNA levels in iGlut pure cultures. n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (E) sCLU levels detected by ELISA from the supernatant of iGlut pure cultures. n=4 per group (2 clones per line and 2 replicates for each clone). (F) CLU mRNA levels of mAst in iGlut-mAst co-cultures. n=4 per group (2 clones per line and 2 replicates for each clone). (G) Three qPCR primer sets that can capture the majority of CLU transcript isoforms (14/17) are used in (H) to detect CLU mRNA levels. Only iGlut-mAst co-cultures of the CD07 line was used. n=6 per group (3 replicates per clone for 2 clones). (I) rs1532278 did not alter the expression of SCARA3 , a CLU -adjacent gene, in iGlut (or when co-cultured with mAst) of the isogenic pairs of both CD05 and CD07 lines. n=10 per group (2 replicates per clone and 2-3 clones per line). Data = mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Journal: medRxiv

    Article Title: Alzheimer’s disease protective allele of Clusterin modulates neuronal excitability through lipid-droplet-mediated neuron-glia communication

    doi: 10.1101/2024.08.14.24312009

    Figure Lengend Snippet: (A) Multiz alignment and phyloP conservation (470 mammals) around rs1532278 (from UCSC hg38 genome browser). (B) JASPAR predicted TF binding sites at rs1532278 and TF expression levels in iGlut (10/23 predicted TFs can be detected by RNA seq). CPM, counts per million reads. (C) DRGX ChIP-qPCR for iGlut-mAst co-cultures of CD07 line on day 30. n=3 per group (one clone with 3 replicates from the CD07 line). (D) CLU mRNA levels in iGlut pure cultures. n=6 per group (2-3 clones per line and 2-3 replicates for each clone). (E) sCLU levels detected by ELISA from the supernatant of iGlut pure cultures. n=4 per group (2 clones per line and 2 replicates for each clone). (F) CLU mRNA levels of mAst in iGlut-mAst co-cultures. n=4 per group (2 clones per line and 2 replicates for each clone). (G) Three qPCR primer sets that can capture the majority of CLU transcript isoforms (14/17) are used in (H) to detect CLU mRNA levels. Only iGlut-mAst co-cultures of the CD07 line was used. n=6 per group (3 replicates per clone for 2 clones). (I) rs1532278 did not alter the expression of SCARA3 , a CLU -adjacent gene, in iGlut (or when co-cultured with mAst) of the isogenic pairs of both CD05 and CD07 lines. n=10 per group (2 replicates per clone and 2-3 clones per line). Data = mean±SEM. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Article Snippet: ELISA quantifications of human CLU (DCLU00, R&D system, specific for human CLU), human Aβ 1-40 (DAB140B, R&D system), and human Aβ 1-42 (DAB142, R&D system) were performed according to the vendors’ protocol.

    Techniques: Binding Assay, Expressing, RNA Sequencing Assay, Clone Assay, Enzyme-linked Immunosorbent Assay, Cell Culture

    (A) Correlation analysis Salmon sorted iGlut data set to our previous published single-cell data sets iGlut (CD05 and CD07) and others published single cell data sets in postmortem brain with various cell types including ex-neuron, ih-neuron, microglia, astrocyte, oligodendrocytes, and OPC. Ast: astrocyte, ex: excitatory neuron, ih: inhibitory neuron, mic, microglia, Oli: oligodendrocyte, and OPC: oligodendrocyte progenitor cell. (B) MDS (Multidimensional scaling) analysis of all transcripts in iGlut and mAst, which are expressed in ≥75% of samples. (C) ELISA quantification of Aβ in the supernatants of iGlut-mAst co-cultures and iGlut pure cultures. n=4 per group (2 clones per line and 2 replicates for each clone). (D) GO Biological process enrichment in significantly downregulated gene sets in iGlut. Blue stars indicate neuron morphology-related pathways. (E) Confirmation of SYP , PSD-95 , and CLU expression levels in iGlut in RNA seq analysis. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Journal: medRxiv

    Article Title: Alzheimer’s disease protective allele of Clusterin modulates neuronal excitability through lipid-droplet-mediated neuron-glia communication

    doi: 10.1101/2024.08.14.24312009

    Figure Lengend Snippet: (A) Correlation analysis Salmon sorted iGlut data set to our previous published single-cell data sets iGlut (CD05 and CD07) and others published single cell data sets in postmortem brain with various cell types including ex-neuron, ih-neuron, microglia, astrocyte, oligodendrocytes, and OPC. Ast: astrocyte, ex: excitatory neuron, ih: inhibitory neuron, mic, microglia, Oli: oligodendrocyte, and OPC: oligodendrocyte progenitor cell. (B) MDS (Multidimensional scaling) analysis of all transcripts in iGlut and mAst, which are expressed in ≥75% of samples. (C) ELISA quantification of Aβ in the supernatants of iGlut-mAst co-cultures and iGlut pure cultures. n=4 per group (2 clones per line and 2 replicates for each clone). (D) GO Biological process enrichment in significantly downregulated gene sets in iGlut. Blue stars indicate neuron morphology-related pathways. (E) Confirmation of SYP , PSD-95 , and CLU expression levels in iGlut in RNA seq analysis. * p <0.05, ** p < 0.01, *** p < 0.001, and **** p < 0.0001.

    Article Snippet: ELISA quantifications of human CLU (DCLU00, R&D system, specific for human CLU), human Aβ 1-40 (DAB140B, R&D system), and human Aβ 1-42 (DAB142, R&D system) were performed according to the vendors’ protocol.

    Techniques: Enzyme-linked Immunosorbent Assay, Clone Assay, Expressing, RNA Sequencing Assay